Lumos Pharma | NLNK - Nettoeinkommen



Nettoeinkommen Veränderung Datum
Agenus USD -25.27M 20.59M 2025-03
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Capricor Therapeutics USD -24.39M 17.27M 2025-03
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -6.98M 360K 2025-09
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Grifols EUR 148.4M 15.76M 2025-09
Incyte USD 299.28M 124.89M 2025-12
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Prothena USD -36.54M 89.23M 2025-09
Sarepta Therapeutics USD -412.23M 232.28M 2025-12